Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-016835
Filing Date
2025-05-14
Accepted
2025-05-14 16:08:01
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cont20250331_10q.htm   iXBRL 10-Q 972114
2 EXHIBIT 10.1 ex_796379.htm EX-10.1 39468
3 EXHIBIT 31.1 ex_773091.htm EX-31.1 15882
4 EXHIBIT 31.2 ex_773092.htm EX-31.2 12661
5 EXHIBIT 32.1 ex_773093.htm EX-32.1 9086
6 EXHIBIT 32.2 ex_773094.htm EX-32.2 6093
12 companylogo.jpg GRAPHIC 10755
13 pipeline2025.jpg GRAPHIC 86982
  Complete submission text file 0001437749-25-016835.txt   5632500

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ctnm-20250331.xsd EX-101.SCH 41732
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctnm-20250331_cal.xml EX-101.CAL 36014
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctnm-20250331_def.xml EX-101.DEF 313685
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctnm-20250331_lab.xml EX-101.LAB 268921
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctnm-20250331_pre.xml EX-101.PRE 336732
68 EXTRACTED XBRL INSTANCE DOCUMENT cont20250331_10q_htm.xml XML 898025
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42001 | Film No.: 25945465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)